Sexual function and satisfaction in heterosexual couples when men are administered sildenafil citrate (Viagra®) for erectile dysfunction:: a multicentre, randomised, double-blind, placebo-controlled trial

被引:68
|
作者
Heiman, J. R.
Talley, D. R.
Bailen, J. L.
Oskin, T. A.
Rosenberg, S. J.
Pace, C. R.
Creanga, D. L.
Bavendam, T.
机构
[1] Indiana Univ, Kinsey Inst Res Sex Gender & Reprod, Bloomington, IN 47405 USA
[2] Urol San Antonio Res, San Antonio, TX USA
[3] Metropolitan Urol, Jefferson, IN USA
[4] Northside Internal Med, Spokane, WA USA
[5] Iowa Clin PC, Des Moines, IA USA
[6] Pfizer Inc, New York, NY USA
关键词
couples; erectile dysfunction; relations; sexual partner; sildenafil citrate;
D O I
10.1111/j.1471-0528.2006.01228.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To investigate the effect of improvement in erectile dysfunction (ED) on sexual function and satisfaction measures in heterosexual couples in which the woman reports that sexual intercourse is unsatisfactory at least half of the time. Design Multicentre, double-blind, placebo-controlled study. Setting Outpatient medical clinics. Population Hundred and eighty men with ED and their female partners in whom sexual intercourse was satisfactory about half the time or less (score of <= 3 on the Female Partner of ED Subject Questionnaire question 3 [FePEDS Q3]). Methods Men were randomised to flexible-dose sildenafil (25, 50, and 100 mg) or placebo as needed for 12 weeks. Main outcome measures Primary: FePEDS Q3 ('Over the past four weeks, when you had sexual intercourse, how often was it satisfactory for you?') scored as 0 (no sexual activity) and 1 (almost never or never) to 5 (almost always or always). Secondary, partners: Sexual Function Questionnaire, Female Sexual Function Index (FSFI), and ED Inventory of Treatment Satisfaction (EDITS) partner version (EDITS-Partner). Secondary, men: International Index of Erectile Function (IIEF), General Efficacy Questions, event log data, Self-Esteem And Relationship questionnaire, and EDITS. Secondary, partners and men: Dyadic Adjustment Scale. Results The intention-to-treat population included 85 sildenafil recipients (mean age 59 +/- 12 years) and 91 placebo recipients (mean age 57 +/- 11 years). Most partners (aged 20-79 years; mean, 54 years) were postmenopausal. Sildenafil compared with placebo couples had greater improvement in the primary outcome (FePEDS Q3 [P < 0.0001]) and in sexual function, intercourse success rates, and secondary sexual satisfaction measures (FSFI satisfaction domain [P < 0.0001] and IIEF satisfaction domains [P < 0.001]) and had higher treatment satisfaction (EDITS and EDITS-Partner; P < 0.0001). Several predictors of improvement were identified, and improvement in one member of the couple correlated positively with improvement in the other member. Conclusions The interdependence of sexual function and sexual satisfaction measures between members of couples consisting of men with ED and sexually healthy women reporting infrequent satisfactory sexual intercourse underscores the importance of including partners in ED treatment discussions.
引用
收藏
页码:437 / 447
页数:11
相关论文
共 50 条
  • [31] Efficacy of sildenafil citrate 100 mg for 8 hours: Double-blind placebo-controlled trials in mild to moderate erectile dysfunction
    Steidle, Christopher P.
    McCullough, Andrew R.
    Kaufman, Joel
    Goldfischer, Evan R.
    Klee, Brian
    Carlson, Martin
    JOURNAL OF SEXUAL MEDICINE, 2008, 5 : 27 - 27
  • [32] Sildenafil citrate improves erectile function: a randomised double-blind trial with open-label extension
    McVary, K. T.
    Kaufman, J.
    Young, J. M.
    Tseng, L.-J.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (11) : 1843 - 1849
  • [33] Relationship Between Erectile Functioning and Psychosocial Functioning Following Treatment with VIAGRA, μ (Sildenafil Citrate): Results From an International, Multicenter, Randomized, Double-blind, Placebo-controlled Trial
    Glina, S.
    Cappelleri, J. C.
    Duttagupta, S.
    Sherman, N.
    Stecher, V. J.
    Siegel, R.
    Tseng, L.
    JOURNAL OF SEXUAL MEDICINE, 2004, 1 : 55 - 55
  • [34] Vardenafil improves sexual function and treatment satisfaction in couples affected by erectile dysfunction (ED): A randomized, double-blind, placebo-controlled trial in PDE5 inhibitor-naive men with ED and their partners
    Edwards, David
    Hackett, Geoff
    Collins, Owen
    Curram, John
    JOURNAL OF SEXUAL MEDICINE, 2006, 3 (06): : 1028 - 1036
  • [35] Double-blind, Placebo-controlled Trial of Sildenafil in Phallometric Testing
    Kolla, Nathan J.
    Klassen, Philip E.
    Kuban, Michael E.
    Blak, Thomas
    Blanchard, Ray
    JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW, 2010, 38 (04): : 502 - 511
  • [36] Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial - Comment
    Wyllie, MG
    BJU INTERNATIONAL, 2004, 94 (09) : 1309 - 1309
  • [37] Female partners of men with erectile dysfunction receiving vardenafil have improved sexual function: Results from a randomized double-blind placebo-controlled trial
    Fisher, W
    Rosen, RC
    Brock, G
    Karlin, G
    Pommerville, P
    Goldstein, I
    Bangerter, K
    JOURNAL OF SEX RESEARCH, 2006, 43 (01) : 17 - 17
  • [38] Sildenafil citrate improves self-esteem, confidence, and relationships in men with erectile dysfunction: Results from an international, multi-center, double-blind, placebo-controlled trial
    Althof, SE
    O'Leary, MP
    Cappelleri, JC
    Hvidsten, K
    Stecher, VJ
    Glina, S
    King, R
    Siegel, RL
    JOURNAL OF SEXUAL MEDICINE, 2006, 3 (03): : 521 - 529
  • [39] Impact on Erectile Function and Sexual Quality of Life of Couples: A Double-Blind, Randomized, Placebo-Controlled Trial of Tadalafil Taken Once Daily
    Rubio-Aurioles, Eusebio
    Kim, Edward D.
    Rosen, Raymond C.
    Porst, Harmut
    Burns, Patrick
    Zeigler, Haoyue
    Wong, David G.
    JOURNAL OF SEXUAL MEDICINE, 2009, 6 (05): : 1314 - 1323
  • [40] Mitoxantrone in progressive multiple sclerosis:: a placebo-controlled, double-blind, randomised, multicentre trial
    Hartung, HP
    Gonsette, R
    König, N
    Kwiecinski, H
    Guseo, A
    Morrissey, SP
    Krapf, H
    Zwingers, T
    LANCET, 2002, 360 (9350): : 2018 - 2025